CHEMICAL/BIOLOGICAL DEFENSE (ACD&P)

Abstract

The projects in this program element (PE) support technology, engineering, integration, and life-cycle cost risk reduction activities (e.g. component development, prototyping, and experimentation) prior to Milestone B. Individual projects include: - Contamination Avoidance (CA4): development of reconnaissance, detection, identification, and hazard prediction equipment, hardware, and software that minimize CBR contamination and prevent further cross-contamination during operations. - Decontamination Systems (DE4): development of Contamination Mitigation (ConMit) systems utilizing solutions that will remove and/or detoxify contaminated material without damaging combat equipment, personnel, or the environment. - Individual Protection (IP4): development of the next generation protective ensembles (e.g., suits, boots, and gloves) which enable the Joint Force to survive and continue the mission in CBR contaminated environments. - Information Systems (IS4): component development and prototyping of information architectures and applications for shaping the battlespace against CBRN threats. - Medical Biological Defense (MB4): development of medical countermeasure platform technologies, medical countermeasures (vaccines and therapeutics), reagents, assays, and diagnostic equipment to provide an effective capability for medical defense against biological warfare agent threats facing U.S. Forces in the field. - Medical Chemical Defense (MC4): development of medical materiel and other medical equipment items (e.g., diagnostic equipment, prophylactic, pre-treatment, and therapeutic drugs, and individual/casualty decontamination compounds) necessary to provide an effective capability for medical defense against chemical warfare agent threats facing U.S. Forces in the field. - Test and Evaluation (TE4): critical test capabilities, planning, and infrastructure improvements/modifications necessary to evaluate Chemical, Biological, Radiological, and Nuclear (CBRN) Defense systems in realistic operating environments. The projects in this PE support the advanced component technology development phase of the DoD acquisition system and are therefore correctly placed in Budget Activity 4.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2020
Source ID
0603884BP_4_0400_PB_2020
Change Summary Explanation
Funding: FY18 (-$9.925M): Congressional Directed Reductions. FY18 ((-$.402M): Reprogramming adjustments to balance overall portfolio efforts. FY18 (-$2.869M): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY19 (-$14.000M): Congressional Directed Reductions. FY20 (+$8.000M): Program Increase for Advanced Development and Manufacturing (ADM) Capability Development. FY20 (-$6.095M): Program adjustments to balance overall portfolio efforts and resource Services highest priority detection, protection, and MCM development efforts in BA5. Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Chemical Detectors
  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemical Weapons
  • Command And Control
  • Detection
  • Detectors
  • Equine Encephalitis
  • Information Systems
  • Medical Personnel
  • Situational Awareness
  • Systems Engineering
  • Test And Evaluation
  • Therapy
  • Unmanned Aerial Systems
  • Viruses
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Biotechnology

Related Documents